Search for Clinical Trial Results
Cholangiocarcinoma - 66 Studies Found
Status | Study |
Recruiting |
Study Name: Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2014-04-28 Interventions:
|
Active, not recruiting |
Study Name: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2015-06-24 Interventions:
|
Completed |
Study Name: Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib Condition: Cholangiocarcinoma Date: 2006-04-28 |
Recruiting |
Study Name: A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas Condition: Cholangiocarcinoma Date: 2013-05-15 Interventions:
|
Terminated |
Study Name: Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2009-09-10 Interventions: Drug: WST11 WST11-mediated VTP will consist of the combination of a single IV administration of WST11 at |
Completed |
Study Name: A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma Condition: Unresectable and Advanced Cholangiocarcinoma Date: 2012-10-22 Interventions: Drug: Sunitinib sunitinib dose :37.5mg/day Other Nam |
Recruiting |
Study Name: Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy Condition: Cholangiocarcinoma Date: 2016-10-04 Interventions: Drug: INCB054828 INCB054828 once daily |
Withdrawn |
Study Name: Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2008-07-07 Interventions: Drug: Gemcitabine, Oxaliplatin, Photodynamic therapy (Photosan®) |
Completed |
Study Name: Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2006-07-10 Interventions:
|
Recruiting |
Study Name: A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma Condition: Advanced Cholangiocarcinoma Date: 2014-05-12 Interventions: Drug: BGJ398 Capsule for oral use |